Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer.

World journal of urology - 1 Apr 2013

Pao Jiunn-Bey, Yang Ying-Pi, Huang Chun-Nung, Huang Shu-Pin, Hour Tzyh-Chyuan, Chang Ta-Yuan, Lan Yu-Hsuan, Lu Te-Ling, Lee Hong-Zin, Juang Shin-Hun, Huang Chao-Yuan, Bao Bo-Ying

Abstract excerpt

PURPOSE: Molecular epidemiology studies have shown that vitamin D receptor (VDR) gene polymorphisms are associated with prostate cancer risk. However, the prognostic value of these polymorphisms on clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy (ADT) has not been determined. METHODS: We evaluated the association of five common VDR polymorphisms, ApaI, Tru9I, BsmI, FokI, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgen Antagonists
Share to Antineoplastic Agents, Hormonal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Gonadotropin-Releasing Hormone

Share to Haplotypes

Share to Orchiectomy

Share to Prostatic Neoplasms

Share to Receptors, Calcitriol

Source

Identifiers

PMID: 22193519
DOI: 10.1007/s00345-011-0813-x

Genes

VDR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer.PMID 22193519Read ↗

Vitamin D receptor genotypes/haplotypes and prostate cancer risk.Semantic proximity Read ↗

Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review.Semantic proximity Read ↗

Association of VDR polymorphisms ( Taq I and Bsm I) with prostate cancer: a new meta-analysis.Semantic proximity Read ↗

Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Genetic polymorphisms of vitamin D receptor and the risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.Semantic proximity Read ↗

Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy.Semantic proximity Read ↗

Association of vitamin D receptor polymorphisms with the risk of prostate cancer in the Han population of Southern China.Semantic proximity Read ↗

Vitamin D pathway gene variants and prostate cancer prognosis.Semantic proximity Read ↗

Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy.Semantic proximity Read ↗

Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy.Semantic proximity Read ↗

Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.